VDVijay Mais-Ogly Dzhafarov

Vijay Mais-Ogly Dzhafarov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Vijay Mais-Ogly Dzhafarov has a total of 58 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Optimal metrics for SUV values using 18F-FDG PET/MRI in patients with drug-resistant epilepsy and verified epileptogenic lesion

    by Tatiana M. Rostovtseva, Mikhail B. Dolgushin, Rostislav V. Nadelyaev, Andrey V. Dvoryanchikov, Yulia V. Rubleva, Vidzhai M. Dzhafarov, Ilya V. Senko, Elena A. Baranova, Yulia A. Voronkova, Olga I. Patsap, et al.

    Background. Epilepsy is one of the most common neurological disorders, affecting individuals of all ages. For patients meeting the criteria for drug-resistant epilepsy established by the International League Against Epilepsy (ILAE), surgery is the most effective treatment option. The success of surgical outcomes depends directly on the precise localization of the epileptogenic focus. Positron emission tomography combined with magnetic resonance imaging (PET/MRI) is a novel hybrid diagnostic modality that may improve detection of the epileptogenic zone in complex diagnostic cases, including patients with MRI-negative epilepsy. Detecting the area of 18F-fluorodeoxyglucose (18F-FDG) hypometabolism in the epileptogenic focus is traditionally based on visual analysis; quantitative analysis techniques for hypometabolism in the epileptogenic focus have not been standardized and remain a subject of scientific investigation. Aim: To determine the optimal calculation metric (uptake index) of quantitative standardized uptake value (SUV) for detecting the epileptogenic focus in patients with drug-resistant epilepsy using brain 18F-FDG PET/MRI. Materials and methods. We retrospectively analyzed data from hybrid 18F-FDG PET/MRI brain studies performed in 10 healthy volunteers and 19 patients with drug-resistant epilepsy in whom the localization of the epileptogenic focus identified on PET/MRI was confirmed by surgical resection or invasive video-EEG monitoring. Results. The greatest variability in quantitative SUVmax and SUVmean was observed in patients with focal cortical dysplasia (FCD), while moderate variability in semi-quantitative SUVmax and SUVmean was observed in patients with mesial temporal sclerosis (MTS). The smallest reductions in SUVmax were observed in patients with FCD and MTS; for these patients, the SUVmean parameter was the best for localizing the epileptogenic focus. Analysis of brain PET/MRI data from patients with MRI-negative and MRI-positive epilepsy revealed no significant differences in semi-quantitative 18F-FDG metabolism parameters. In the group of patients with temporal lobe epilepsy, lower SUVmax and SUVmean were recorded, which may reflect the normally observed lower 18F-FDG metabolism in the temporal lobes compared to the cortex of other brain regions. Conclusion. Statistical analysis of quantitative 18F-FDG metabolism parameters in the epileptogenic focus confirmed by invasive methods indicates that the SUVmean parameter is optimal for identifying hypometabolic areas suspicious for the epileptogenic focus, due to its lower standard deviations and more homogeneous values within the sample, particularly in patients with FCD and MTS.

  • Open Access

    FUS-thalamotomy in the correction of tremors in fragile X-associated tremors/ataxia syndrome (FXTAS)

    by Elena A. Katunina, Natalia N. Shipilova, Veronika A. Bogomazova, Roman A. Gryaznev, Elena A. Malykhina, Mikhail B. Dolgushin, Ivan S. Gumin, Vidzhai M. Dzhafarov

    BACKGROUND: Tremor/ataxia syndrome associated with a brittle X chromosome is a rare neurodegenerative disease. CLINICAL CASE DESCRIPTION: The article presents the clinical case of a 62 years old patient, suffering from hand tremors from the age of 5–7 with gradual onset of tremors in the head (with vocal jitter) and in the chin with further development of ataxia and mild dysarthria. After DNA-testing, the patient was diagnosed with increased levels of cytosine-guanine-guanine (CGG) trinucleotide repeats in the FMR1 gene of the Х-chromosome. Due to the absence of effect from conservative therapy and the unremitting progression of the severity of tremors, reaching the incapacitating levels, the patient underwent the stereotaxic destruction of the ventrolateral nucleus of the thalamus with focused ultrasound guided by magnetic resonance imaging (MRI) on the left side. During the process of the surgical intervention, a total of six ultrasonic exposures were delivered with achieving, based on the results of MR-thermometry, the average temperature levels of 57–60°С. The duration of treatment was 120 minutes. Right after the surgical intervention, significant clinical improvement was achieved: by 48% according to the Clinical Rating Scale for Tremor (CRST), by 80% according to the hemi-CRST (modified version of CRST for the evaluation of tremors on a single side of the body); the improvement of everyday activity according to the CRST (part С) was 87%. Thalamotomy with focused ultrasound (FUS-thalamotomy) did not cause any significant effect in this patient in terms of the aggravation of ataxia, of coordination or speech disorders. CONCLUSION: The presented clinical case demonstrates the complexity of setting the FXTAS diagnosis, as well as the necessity for the differential diagnostics of fragile Х-associated tremors and ataxia syndrome with a vast spectrum of hereditary diseases, manifesting with extrapyramidal symptoms and cognitive dysfunction. Due to the low efficiency of symptomatic medication therapy in FXTAS patients, the methods of functional neurosurgery should be considered, among which, recently more attention is gained by the MRgFUS method as the least invasive and as the safe one in the elderly individuals. As of today, the experience of performing the MRgFUS in patients with FXTAS syndrome is insignificant and contains the descriptions of single cases in foreign literature. This clinical case, the first experience of performing FUS-MRI in a patient with FXTAS syndrome in Russia, has demonstrated the potential of this approach, but further studies involving a larger number of patients and a longer observation period are certainly needed.

  • Treatment of drug-resistant epilepsy associated with temporal lobe cavernomas

    by V. V. Krylov, O. O. Kordonskaya, A. A. Zalogina, I. V. Senko, V. M. Dzhafarov, Yu. V. Rubleva, S. G. Burd, N. V. Pantina, Yu. A. Voronkova, E. A. Baranova, et al.

    Pharmacoresistance (drug-resistance) occurs in 40 % of cases of structural epilepsy associated with cavernous malformations. The surgical strategy in the treatment of such patients aims, on one hand, to eliminate the epileptogenic focus and achieve seizure control; on the other hand, to remove the cavernoma and eliminate the risk of recurrent hemorrhage. The following surgical options are identified: 1) removal of only the cavernous malformation; 2) microsurgical removal of the cavernoma with a perifocal area of hemosiderin and a zone of gliosis; 3) stereotactic radiosurgery method. In cases of temporal cavernoma, anterior medial temporal lobectomy is highlighted as an additional method of surgical treatment. This localization requires a special approach to the choice of surgical strategy depending on the location of the cavernoma in relation to the structures of the hippocampal complex, the presence of secondary epileptogenic foci and the duration of epilepsy. Aim of the work – to analyze the current data on the examined topic, aspects of surgical treatment of patients with structural focal epilepsy associated with cavernomas, using the example of three clinical cases. Clinical examples are presented based on data from three patients operated on at the Federal Center of Brain Research and Neurotechnologies of the Federal Medical Biological Agency (FMBA) of Russia between 2022 and 2023. A literature review was conducted on treatment options for this category of patients. Articles were searched on the scientific platforms PubMed, Cochrane Library, eLIBRARY. RU, and the Journal of Neurosurgery, using the following search terms: cavernous malformation, structural epilepsy, temporal focal epilepsy.

  • Open Access

    The hybrid brain PET/MRI method with 18F-FDG in the diagnostics of focal cortical dysplasia in patients with focal drug-resistant epilepsy

    by Tatiana M. Rostovtseva, Mikhail B. Dolgushin, Andrey V. Dvoryanchikov, Rostislav V. Nadelyaev, Mariya A. Karalkina, Vidzhai M. Dzhafarov, Yulia V. Rubleva, Elena A. Baranova, Olga I. Patsap, Sergey G. Burd, et al.

    BACKGROUND: Up to 30% of the patients with epilepsy are resistant to drug therapy. One of the leading causes of drug-resistant epilepsy in adults and children is the focal cortical dysplasia. The complete resection of the epileptogenic focus in 60–70% of the cases results in the complete resolving of epileptic seizures, however, its detection and determining its margins by using magnetic resonance imaging (MRI) could be a difficult task. Positron emission tomography combined with MRI (PET/MRI) is a new hybrid method of diagnostics, which can be used in case of negative and indefinite MRI results, as well as in case of non-compliance of the MRI findings to the data from videoelectroencephalography (video-EEG-monitoring). AIM: To evaluate the diagnostic possibilities of the hybrid brain PET/MRI method with the use of the radiopharmaceutical — Fluorodeoxyglucose (18F-FDG) in detecting the focal cortical dysplasia in patients with focal drug-resistant epilepsy and to analyze the metabolic patterns in cases of focal cortical dysplasia of various type and location. METHODS: The retrospective analysis of data from 23 patients included the comparison of data from the brain PET/MRI with 18F-FDG, from the MRI and from the video-EEG-monitoring, as well as the analysis of 18F-FDG hypometabolism patterns in cases of focal cortical dysplasia of various types and locations. RESULTS: Focal cortical dysplasia was found in 13 (56.5%) patients by means of MRI, in 22 (95.6%) — by means of PET/MRI with 18F-FDG; 6 (26.1%) were MRI-negative, while in 3 (13%) cases the signs of focal cortical dysplasia were found upon the retrospective targeted analysis of MRI images in the 18F-FDG hypometabolism zone. Small focal area of 18F-FDG hypometabolism in our research was found only when the epileptogenic focus was located in the frontal lobe, which was 75% of the cases of the frontal variant of FCD. In all the cases of the temporal location, the zone was spreading to two and more gyri. As of the moment of article publication, the absence of seizures acc. to the classification by J. Engel (Engel I) in the postoperative period was reported for 11 (84.6%) of 13 operated patients, the Engel II class outcome was registered in 1 (4.3%) patient. CONCLUSION: Brain PET/MRI with 18F-FDG in patients with focal drug-resistant epilepsy increases the detection rates of focal cortical dysplasia by 39% comparing to MRI, including the MRI-negative patients and the patients with minor structural changes. The analysis of PET/MRI images in patients with suspected presence of epileptogenic focus of frontal location requires special attention.

  • Repeated unilateral FUS thalamotomy in patients with tremor-dominant forms of Parkinson’s disease

    by N.N. Shipilova, E.A. Katunina, N.V. Titova, E.A. Malykhina, D.A. Katunin, A.R. Pogorova, V.M. Dzhafarov, I.S. Gumin, I.V. Senko, M.B. Dolgushin

    Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive therapy for tremor based on focusing ultrasound in the deep parts of the brain without damaging adjacent tissues. Despite many benefits, the procedure has its side effects. In addition, some patients show a relapse of tremor some time after the procedure. The question of the need for repeated surgery on the same side remains debatable. The article presents two clinical cases of repeated unilateral FUS thalamotomy in patients with Parkinson’s disease (PD) due to the relapse of tremor after the first procedure. Factors that may contribute to the effectiveness of the intervention or increase the risk of adverse events are described. Further studies are needed to establish the indications and contraindications for repeated FUS thalamotomy on the same side in patients with PD.


  • Open Access

    The Results of a 12-Month Open-Label Follow-Up Study with MRI Monitoring of Patients with Parkinson’s Disease After MRI-Guided FUS

    by Elena Anatolievna Katunina, Mikhail Yurievich Martynov, Vsevolod Vadimovich Belousov, Nataliya Vladimirovna Titova, Mikhail Borisovich Dolgushin, Raisa Tairovna Tairova, Natalia Nikolaevna Shipilova, Madina Zamirovna Ivanova, Ilya Vladimirovich Senko, Ivan Sergeevich Gumin, et al.

    Background: Tremor-dominant Parkinson’s disease (TDPD) is the most common subtype of PD. Tremor is difficult to treat and less than 50% of patients respond to dopaminergic medications. Magnetic resonance guided focused ultrasound (MRgFUS) thalamotomy is an incisionless noninvasive method for treating pharmacoresistant tremor in PD patients, but its effect on progression of PD is unknown. In this study, we investigate the efficacy of MRgFUS thalamotomy on progression of motor and non-motor symptoms, using a levodopa equivalent daily dose (LEDD) requirement. Methods: A total of 21 PD patients with ineffective tremor correction by medical therapy underwent MRgFUS thalamotomy. Assessments of motor and non-motor symptoms, adverse events (AE), changes in LEDD, and evolution of FUS (focused ultrasound) lesion were performed on the day before surgery, and then 2 days, as well as 3, 6, and 12 months, after the procedure. Results: On the 2nd day after FUS thalamotomy, 11 patients were tremor-free and, in 10 patients, tremor decreased by 80–90% with a concomitant reduction in hypokinesia and rigidity. By the end of the 12th month, 5 patients remained tremor-free; in 11 patients, mild/moderate tremor re-emerged; and in 5 patients, there was a relapse of severe tremor. Quality of life (QoL) and activities of daily living (ADL) improved significantly at 3 months and remained stable thereafter. Cognitive function improved in patients with baseline MoCA score < 26 points at 3 months after FUS. Anxiety progressed between baseline and end of follow-up. By the end of the follow-up period, LEDD was lowered or stable in 9 patients. Four patients had persistent mild AE. Conclusions: This open label study suggests a beneficial effect of MRgFUS in reducing tremor, hypokinesia, and rigidity and improving QoL, ADL, and cognitive function in TDPD patients in the short term, although long-term data needs to be collected in further studies.


  • A prospective study of MRI-guided focused ultrasound thalamotomy in essential tremor

    by R.A. Gryaznev, N.N. Shipilova, V.M. Dzhafarov, I.S. Gumin, E.A. Malykhina, D.A. Katunin, A.R. Pogorova, I.V. Senko, M.B. Dolgushin, E.A. Katunina

    Objective. To study the effect of magnetic resonance imaging-guided focused ultrasound (MR-FUS) on the motor and non-motor symptoms of essential tremor (ET) (cognitive functions, anxiety, depression, apathy, sleep disorders), as well as to establish association between adverse events (AEs) and the technical parameters of the surgery, postablation neuroimaging changes in the brain matter, and clinical and demographic factors. Material and methods. Twenty-two patients with disabling drug-resistant ET were prospectively evaluated prior to unilateral ventral intermediate nucleus (Vim) FUS thalamotomy, and at 24 hours, 3, 6, and 12 months postoperatively. The change of tremor was assessed using the Clinical Rating Scale for Tremor (CRST). Non-motor symptoms were assessed using the Montreal Cognitive Assessment (MoCA), the Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI), the Apathy Scale, and the Epworth Sleepiness Scale. The Tinetti test was used to assess balance and gait. The quality of life for patients with ET was assessed using the Quality of Life in Essential Tremor Questionnaire (QUEST). MRI with a magnetic field strength of 3.0 T was performed immediately after surgery, as well as at 24 hours, 3, 6, and 12 months post-surgery. Results. MR-FUS led to a significant reduction in tremor in the extremities of the contralateral thalamotomy site; the mean total CRST and hemi-CRST scores decreased by 78% and 80% (p0.05). Mild adverse events occurred in 45% of patients immediately after surgery, and most of the AEs regressed by Month 3 of follow-up. The lesion volume and postoperative edema were significantly correlated with a decrease in the total CRST score at 6 and 12 months postoperatively (r=–1, p=0.01). The results of the correlation analysis showed that patients with AEs after FUS-thalamotomy had larger foci of necrosis and postoperative edema, and also had a significantly shorter duration of surgery (p=0.042). However, the number of sonications (both verification and therapeutic), the power of ultrasound waves, and the maximum exposure temperatures in the patients of the compared groups did not differ significantly. Conclusion. The results of an open prospective study confirmed the effectiveness of unilateral FUS thalamotomy of the Vim nucleus of the thalamus for the treatment of ET. There was no significant effect on the non-motor manifestations of ET. All reported AEs were mild and transient. The risk of AEs was determined by the volume of the lesion and postoperative edema, as well as the duration of surgery.


  • Surgical treatment of secondary trigeminal neuralgia

    by V.M. Dzhafarov, E.N. Rozhnova, V.V. Gosteva, S.A. Melchenko, A.I. Volkov, O.V. Boyko, I.V. Senko

    Objective. To present a case series analysis of surgical treatment of patients with secondary trigeminal neuralgia. Material and methods. The treatment of 8 patients with secondary trigeminal neuralgia who underwent surgery since 2021 was analyzed. All records, neuroimaging archive, and follow-up observations were reviewed. Results. There were 5 patients with trigeminal neuralgia associated with multiple sclerosis; with neurosarcoidosis (n=1); with tumor (n=1); with unspecified degenerative disease (n=1). The mean age was 61 years (from 48 to 73), the mean duration of disease was 7.2 years (from 5 to 13). Radiofrequency ablation (RF) was performed in 4 cases, balloon compression in 3 cases, tumor removal in 1 case. Relief of trigeminal neuralgia after surgery was observed in 7 patients, partial reduction in 1 patient. A complication was noted in a patient with neurosarcoidosis after RF with the appearance of dysesthesia, dry eye. The mean follow-up was 10 months (1 to 29). Pain recurrence occurred in 2 patients, one of them underwent the surgery twice. Conclusion. Surgical treatment of patients with secondary trigeminal neuralgia contributes to pain relief.


  • Open Access

    Thalamotomy with focused ultrasound in the treatment of musician’s dystonia

    by V. M. Dzhafarov, A. I. Kholyavin, M. E. Amelin, M. Yu. Dzhafarova, K. S. Zolotareva, И. В. Сенько

    Background. Approximately from 0.5 to 8 % professional musicians may suffer from focal dystonia. Stereotactic surgery is option if conservative therapy is failed. Thalamotomy has been reported in limited series in the world literature.Aim. To demonstrate a clinical case of thalamotomy with focused ultrasound in a professional guitarist with focal dystonia of the hand.Materials and methods. A 40‑year‑old patient suffered from spasms of the fingers while playing the guitar since 2009. Patient lost professional skills and changed his activities due to progression and severity of disease. He visited our clinic for surgical treatment, stereotactic ventro‑oral thalamotomy by transcranial focused ultrasound was considered.Results. Thalamotomy provided complete reduction of dystonia without complications. On the 2nd day after the procedure, the patient discharged. In a week mild dysarthria was noticed, which did not affect daily activities and completely regressed within a month. A month later, the patient was able to return to concert performance. The follow‑up period was 6 months with no symptoms of the disease.Conclusion. Successful clinical case of focused ultrasound thalamotomy in patient with musician’s dystonia is presented.


  • Open Access

    Transcranial focused ultrasound in neurosurgery: therapeutic possibilities and experimental studies

    by V. I. Skvortsova, V. V. Belousov, V. M. Dzhafarov, И. В. Сенько, V. V. Krylov

    Introduction. Since modern technologies have managed to bypass the bone barrier for ultrasound waves, the arsenal of neurosurgical instruments has been replenished with transcranial focused ultrasound (FUS). The combination of this method with magnetic resonance imaging (MRI) allows you to perform operations under the direct control of the location of the focus of destruction and the degree of its severity during the procedure.Aim. To present a review of the literature on the modern application of the focused ultrasound under MRI control (MRgFUS) method in neurosurgery. Ultrasound has been used in medicine mainly for diagnostic purposes for decades. Modern technologies have led to the possibility of using ultrasound in neurosurgery for therapeutic purposes without open intervention. Today transcranial MRgFUS is an innovation in medicine, expanding the horizons of minimally invasive surgery. The conducted studies of the focused ultrasound method prove the effective treatment of tremor and a number of other pathologies, and many scientific projects represent promising areas.Conclusion. The use of the MRgFUS method opens up broad prospects.